Comprehensive discussion with docs ups cancer screening

April 29, 2013
Comprehensive discussion with docs ups cancer screening
Having more comprehensive discussions about colorectal cancer screening with primary care providers is associated with increased odds of screening, according to a study published in the April issue of the American Journal of Managed Care.

(HealthDay)—Having more comprehensive discussions about colorectal cancer (CRC) screening with primary care providers (PCPs) is associated with increased odds of screening, according to a study published in the April issue of the American Journal of Managed Care.

David M. Mosen, Ph.D., M.P.H., from Kaiser Permanente Northwest in Portland, Ore., and colleagues examined the between the comprehensiveness of CRC screening discussion by PCPs and the completion of screening in a observational study involving 883 participants overdue for CRC screening. Of the 249 participants who completed screening, 84 percent were surveyed about their PCPs' discussion of CRC screening and patient beliefs pertaining to screening.

The researchers found that the average score for comprehensiveness of CRC discussion was 0.4 (range 0 to 1) and the average score for perceived benefits of screening was 4.0 (range 1 to 5). Almost all completed the fecal immunochemical test (95.2 percent). The odds of screening were significantly increased with more comprehensive discussion of CRC screening (odds ratio [OR], 1.51). Increased screening was also associated with higher perceived benefits (OR, 1.46) and with one or more PCP visits (OR, 5.82).

"We found that patients' self-report of more comprehensive discussion of CRC screening by PCPs and a greater perceived level of benefit were independently associated with receipt of CRC screening," the authors write. "This suggests that CRC screening efforts may be usefully directed toward increasing the intensity of screening discussion by PCPs and other care providers."

Explore further: Study examines adherence to colorectal cancer screening recommendations

More information: Full Text

Related Stories

Study examines adherence to colorectal cancer screening recommendations

April 9, 2012
Patients for whom colonoscopy was recommended were less likely to complete colorectal cancer screening than those patients for whom fecal occult blood testing (FOBT) was recommended or those patients who were given a choice ...

Inclusion of CTC as HEDIS screening modality could increase colorectal cancer screening compliance

January 10, 2013
Availability of CT colonography (CTC), commonly known as virtual colonoscopy, is increasing colorectal cancer (CRC) screening rates across military medical facilities. Inclusion of CTC as a Healthcare Effectiveness Data and ...

Study says screening accounts for much of black/white disparity in colorectal cancer

May 3, 2012
A new study finds differences in screening account for more than 40 percent of the disparity in colorectal cancer incidence and nearly 20 percent of colorectal cancer mortality between blacks and whites. Differences in stage-specific ...

Patient navigators appear to improve colorectal cancer screening rate in ethnically diverse patients

May 23, 2011
Among low-income patients who are black or whose primary language is not English, patient navigators may help improve colorectal cancer (CRC) screening rates, according to a report in the May 23 issue of Archives of Internal ...

Recommended for you

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.